- Home
- SLDB vs OMI Comparison
SLDB vs OMI Comparison
Compare SLDB & OMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLDB
- OMI
- Stock Information
- Founded
- SLDB 2013
- OMI 1882
- Country
- SLDB United States
- OMI United States
- Employees
- SLDB N/A
- OMI N/A
- Industry
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- OMI Medical Specialities
- Sector
- SLDB Health Care
- OMI Health Care
- Exchange
- SLDB Nasdaq
- OMI Nasdaq
- Market Cap
- SLDB 464.1M
- OMI 415.6M
- IPO Year
- SLDB 2018
- OMI N/A
- Fundamental
- Price
- SLDB $5.49
- OMI $5.22
- Analyst Decision
- SLDB Strong Buy
- OMI Hold
- Analyst Count
- SLDB 10
- OMI 7
- Target Price
- SLDB $15.00
- OMI $7.96
- AVG Volume (30 Days)
- SLDB 1.0M
- OMI 1.7M
- Earning Date
- SLDB 11-07-2025
- OMI 10-30-2025
- Dividend Yield
- SLDB N/A
- OMI N/A
- EPS Growth
- SLDB N/A
- OMI N/A
- EPS
- SLDB N/A
- OMI N/A
- Revenue
- SLDB N/A
- OMI $10,758,440,000.00
- Revenue This Year
- SLDB N/A
- OMI N/A
- Revenue Next Year
- SLDB N/A
- OMI $1.32
- P/E Ratio
- SLDB N/A
- OMI N/A
- Revenue Growth
- SLDB N/A
- OMI 64.35
- 52 Week Low
- SLDB $2.41
- OMI $4.34
- 52 Week High
- SLDB $7.37
- OMI $15.54
- Technical
- Relative Strength Index (RSI)
- SLDB 48.24
- OMI 54.63
- Support Level
- SLDB $5.48
- OMI $4.35
- Resistance Level
- SLDB $6.09
- OMI $5.60
- Average True Range (ATR)
- SLDB 0.37
- OMI 0.27
- MACD
- SLDB -0.03
- OMI 0.10
- Stochastic Oscillator
- SLDB 28.26
- OMI 72.22
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.
About OMI Owens & Minor Inc.
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.